Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus

December 2016

Look for Basaglar (BAY-zuh-glar) to replace Lantus on home med lists...as some insurers drop Lantus from their formularies in 2017.

Basaglar is a new brand of glargine U-100...NOT a Lantus generic.

Whether Basaglar makes its way to your hospital formulary may depend on whether your hospital stocks insulin pens...since Basaglar is only available as a KwikPen device.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Acute Pain Follow the Latest Thinking when Treating ACUTE Pain in Chronic Opioid Patients
Heart Failure Don't Add Tolvaptan (Samsca) to Improve Diuresis in HF Patients
Immunology Stick to Lower Infusion Rates for Renal Patients Receiving Carimune NF
Insulin Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
Gout Consider a Corticosteroid Over an NSAID for Acute Gout
Pregnancy Evaluate Pregnant Women for VTE Risks on Admission
Cancer Add Non-Opioids for Bone and Neuropathic Pain in Cancer Patients
Statins Start Appropriate Diabetes Patients on a Statin
Adverse Events Document Excipient Allergies in the EHR
Diabetes Feel Comfortable Holding NON-Insulin Diabetes Meds in Type 1s
Supplements Feel Comfortable Holding Turmeric on Admission

Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents